Uncontrolled Study to Evaluate Efficacy of Tocilizumab in Patients With Moderate or Severe Rheumatoid Arthritis

NCT02087696 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

122

Enrollment

OTHER

Sponsor class

Conditions

Arthritis, Rheumatoid

Interventions

DRUG: Tocilizumab

Sponsor

Spanish Foundation of Rheumatology

Collaborators

[object Object]